Ken Griffin’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-116,684
Closed -$1.79M 13236
2025
Q4
$1.79M Sell
116,684
-1,238,309
-91% -$13.6M ﹤0.01% 6146
2025
Q3
$13.5M Buy
1,354,993
+763,033
+129% +$7.94M ﹤0.01% 2835
2025
Q2
$5.87M Sell
591,960
-11,023
-2% -$116K ﹤0.01% 3836
2025
Q1
$7.82M Buy
602,983
+598,089
+12,221% +$7.91M ﹤0.01% 3200
2024
Q4
$62.5K Sell
4,894
-438,367
-99% -$5.3M ﹤0.01% 12134
2024
Q3
$4.94M Buy
443,261
+111,887
+34% +$1.23M ﹤0.01% 3967
2024
Q2
$3.72M Buy
331,374
+228,467
+222% +$2.66M ﹤0.01% 4224
2024
Q1
$1.28M Sell
102,907
-156,605
-60% -$2.04M ﹤0.01% 6433
2023
Q4
$3.63M Sell
259,512
-2,344,938
-90% -$32.6M ﹤0.01% 4318
2023
Q3
$38.5M Buy
2,604,450
+152,306
+6% +$2.14M 0.01% 1286
2023
Q2
$31.7M Buy
2,452,144
+2,356,237
+2,457% +$26.8M 0.01% 1426
2023
Q1
$941K Sell
95,907
-725,436
-88% -$7.74M ﹤0.01% 6909
2022
Q4
$8.74M Buy
821,343
+423,446
+106% +$4.92M ﹤0.01% 3010
2022
Q3
$4.15M Sell
397,897
-47,027
-11% -$613K ﹤0.01% 4184
2022
Q2
$5.6M Buy
444,924
+72,589
+19% +$771K ﹤0.01% 3579
2022
Q1
$4.04M Buy
372,335
+146,659
+65% +$1.78M ﹤0.01% 4587
2021
Q4
$3.17M Sell
225,676
-86,941
-28% -$1.43M ﹤0.01% 5230
2021
Q3
$6M Buy
312,617
+190,590
+156% +$2.53M ﹤0.01% 3963
2021
Q2
$1.2M Buy
122,027
+44,438
+57% +$404K ﹤0.01% 7859
2021
Q1
$763K Buy
77,589
+7,963
+11% +$65.7K ﹤0.01% 8754
2020
Q4
$310K Sell
69,626
-2,027,971
-97% -$9.18M ﹤0.01% 9018
2020
Q3
$9.06M Sell
2,097,597
-832,858
-28% -$5.94M ﹤0.01% 2402
2020
Q2
$26M Buy
2,930,455
+2,475,350
+544% +$12.5M 0.01% 1277
2020
Q1
$1.61M Buy
455,105
+385,566
+554% +$1.79M ﹤0.01% 4501
2019
Q4
$398K Buy
69,539
+53,438
+332% +$286K ﹤0.01% 7162
2019
Q3
$58K Sell
16,101
-634,219
-98% -$2.46M ﹤0.01% 8662
2019
Q2
$2.6M Sell
650,320
-294,430
-31% -$1.71M ﹤0.01% 4086
2019
Q1
$6.91M Buy
944,750
+231,948
+33% +$2.27M ﹤0.01% 2534
2018
Q4
$6.52M Sell
712,802
-158,523
-18% -$1.75M ﹤0.01% 2429
2018
Q3
$10.8M Buy
871,325
+769,376
+755% +$10.4M ﹤0.01% 2005
2018
Q2
$1.55M Sell
101,949
-372,553
-79% -$6.44M ﹤0.01% 4489
2018
Q1
$9.42M Buy
474,502
+249,203
+111% +$4.3M 0.01% 1798
2017
Q4
$4.21M Sell
225,299
-903,262
-80% -$18.1M ﹤0.01% 2685
2017
Q3
$24.3M Buy
1,128,561
+1,112,226
+6,809% +$17.6M 0.02% 948
2017
Q2
$158K Sell
16,335
-93,892
-85% -$610K ﹤0.01% 6707
2017
Q1
$656K Buy
110,227
+63,330
+135% +$305K ﹤0.01% 4616
2016
Q4
$185K Sell
46,897
-206,442
-81% -$1.51M ﹤0.01% 6363
2016
Q3
$2.66M Buy
253,339
+224,626
+782% +$3.23M ﹤0.01% 2636
2016
Q2
$419K Sell
28,713
-6,914
-19% -$118K ﹤0.01% 4737
2016
Q1
$685K Sell
35,627
-201,780
-85% -$4.08M ﹤0.01% 3972
2015
Q4
$5.74M Sell
237,407
-938,392
-80% -$23.5M 0.01% 1689
2015
Q3
$28.9M Buy
1,175,799
+1,009,481
+607% +$28.6M 0.03% 677
2015
Q2
$3.9M Buy
166,318
+60,045
+57% +$1.31M ﹤0.01% 2301
2015
Q1
$2.38M Sell
106,273
-29,420
-22% -$564K ﹤0.01% 2850
2014
Q4
$2.29M Buy
+135,693
New +$2.07M ﹤0.01% 2754
2014
Q3
Sell
-6,651
Closed -$95.9K 8165
2014
Q2
$107K Buy
6,651
+4,420
+198% +$66.7K ﹤0.01% 6176
2014
Q1
$40K Sell
2,231
-1,081
-33% -$20K ﹤0.01% 6912
2013
Q4
$65K Buy
3,312
+1,136
+52% +$16.6K ﹤0.01% 5894
2013
Q3
$26K Buy
2,176
+385
+21% +$4.84K ﹤0.01% 6092
2013
Q2
$20K Buy
+1,791
New +$37.7K ﹤0.01% 6063

Other funds holding DVAX

Ken Griffin's DVAX Position: Q1 2026 in Review

Ken Griffin sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 116,684 shares — an estimated $1.79M sold.

Ken Griffin first reported a position in DVAX in Q2 2013 and held it in 50 quarters. The position peaked at $38.5M in Q3 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Ken Griffin reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Ken Griffin sold 116,684 Dynavax Technologies shares in Q1 2026, an estimated $1.79M.
  • Ken Griffin first reported a position in Dynavax Technologies in Q2 2013 and held it in 50 quarters.
  • Ken Griffin's Dynavax Technologies position peaked at $38.5M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.